Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.03%
#3 CoW Protocol CoW Protocol +41.64%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +23.75%
#6 Walrus Walrus +22.87%
#7 Enso Enso +21.16%
#8 Tutorial Tutorial +17.28%
#9 Codatta Codatta +16.14%
#10 Versatize Coin Versatize Coin +12.50%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Classement en actions #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Prix de l'action
$0.117
Dernière synchronisation: 2025-04-04
Capitalisation boursière
$2.45M
Changement (1 jour)
-13.59%
Changement (1 an)
0.00%
Pays
US
Échange Carmell Therapeutics Corporation (CTCX)

Catégorie

Healthcare
Historique du prix de l'action pour Carmell Therapeutics Corporation (CTCX)
Prix de clôture le plus élevé : $0.13 le 2025-04-01

Prix de clôture le plus bas : $9.69 le 2021-09-01
Historique du prix de l'action de Carmell Therapeutics Corporation de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 -52.71%
2024 -92.46%
2023 -63.87%
2022 1.86%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE